Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells

Nature Communications

Volumn 8, Issue , 2017, Pages

  Lee, Jonghyeob ^a   Snyder, Emily R ^a   Liu, Yinghua ^a   Gu, Xueying ^a   Wang, Jing ^a   Flowers, Brittany M ^a   Kim, Yoo Jung ^a   Park, Sangbin ^a   Szot, Gregory L ^b   Hruban, Ralph H ^c   Longacre, Teri A ^a   Kim, Seung K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; NEUROMEDIN U; PROTEIN P53; SMAD4 PROTEIN; CDKN2A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2C; KRAS PROTEIN, HUMAN; NEUROPEPTIDE; PROTEIN P21; SMAD4 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

BIOMARKER; CELLS AND CELL COMPONENTS; DIGESTIVE SYSTEM; GENE EXPRESSION; HISTOLOGY; HOMINID; HORMONE; LESION; MUTATION; PEPTIDE;

ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE K RAS; PANCREAS TUMOR; PANCREATIC DUCT; PANCREATIC INTRAEPITHELIUM NEOPLASIA; ADENOCARCINOMA IN SITU; ADULT; ANIMAL; CELL LINE; CELL TRANSPLANTATION; CYTOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MOUSE; MUTATION; PANCREAS CARCINOMA;

ADENOCARCINOMA IN SITU; ADULT; ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, PANCREATIC DUCTAL; CELL LINE; CELL TRANSPLANTATION; CYCLIN-DEPENDENT KINASE INHIBITOR P18; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; MUTATION; NEUROPEPTIDES; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); SMAD4 PROTEIN; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85014792012     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14686     Document Type: Article

References (41)

1. Hruban, R. H., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25, 579-586 (2001).
2. Basturk, O., et al. A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas. Am. J. Surg. Pathol. 39, 1730-1741 (2015).
3. Kanda, M., et al. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142, 730-733 e739 (2012).
4. Yachida, S., et al. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin. Cancer. Res. 18, 6339-6347 (2012).
5. Scarlett, C. J., Salisbury, E. L., Biankin, A. V., Kench, J. Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology 43, 183-200 (2011).
6. Esposito, I., Konukiewitz, B., Schlitter, A. M., Kloppel, G. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments. World J. Gastroenterol. 20, 13833-13841 (2014).
7. Hingorani, S. R., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450 (2003).
8. Perez-Mancera, P. A., Guerra, C., Barbacid, M., Tuveson, D. A. What we have learned about pancreatic cancer from mouse models. Gastroenterology 142, 1079-1092 (2012).
9. Chang, Z., et al. Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells. Clin. Cancer. Res. 19, 549-559 (2013).
10. Huang, L., et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell-and patient-derived tumor organoids. Nat. Med. 21, 1364-1371 (2015).
11. Kim, J., et al. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep. 3, 2088-2099 (2013).
12. Boj, S. F., et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324-338 (2015).
13. Lee, J., et al. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. eLife 2, e00940 (2013).
14. Brinkman, E. K., Chen, T., Amendola, M., van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).
15. Qin, R., et al. Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1alpha pathway to predict survival in resectable pancreatic cancer. Br. J. Cancer 112, 514-522 (2015).
16. Mahajan, K., et al. Ack1 tyrosine kinase activation correlates with pancreatic cancer progression. Am. J. Pathol. 180, 1386-1393 (2012).
17. Hwang, C. I., Boj, S. F., Clevers, H., Tuveson, D. A. Preclinical models of pancreatic ductal adenocarcinoma. J. Pathol. 238, 197-204 (2016).
18. Yachida, S., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
19. Vogelstein, B., et al. Cancer genome landscapes. Science 339, 1546-1558;2013
20. Furukawa, T., et al. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am. J. Pathol. 148, 1763-1770 (1996).
21. Buchholz, M., et al. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24, 6626-6636 (2005).
22. Prasad, N. B., et al. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 65, 1619-1626 (2005).
23. Dowen, S. E., et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am. J. Pathol. 166, 81-92 (2005).
24. Albazaz, R., Verbeke, C. S., Rahman, S. H., McMahon, M. J. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer. Pancreatology 5, 361-369 (2005).
25. Anandanadesan, R., et al. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J. Gastrointest. Surg. 12, 57-66 (2008).
26. Brighton, P. J., Szekeres, P. G., Willars, G. B. Neuromedin U and its receptors: structure, function, physiological roles. Pharmacol. Rev. 56, 231-248 (2004).
27. Alfa, R. W., et al. Suppression of insulin production and secretion by a decretin hormone. Cell Metab. 21, 323-333 (2015).
28. Ketterer, K., et al. Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. Cancer Lett. 277, 72-81 (2009).
29. Rangarajan, A., Weinberg, R. A. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 3, 952-959 (2003).
30. Guerra, C., et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11, 291-302 (2007).
31. Guerra, C., et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19, 728-739 (2011).
32. Ishikawa, F., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor g chainnull mice. Blood 106, 1565-1573 (2005).
33. Brosens, L. A., Hackeng, W. M., Offerhaus, G. J., Hruban, R. H., Wood, L. D. Pancreatic adenocarcinoma pathology: changing 'landscape'. J. Gastrointest. Oncol. 6, 358-374 (2015).
34. von Figura, G., et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat. Cell Biol. 16, 255-267 (2014).
35. Ouyang, H., et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am. J. Pathol. 157, 1623-1631 (2000).
36. Erkan, M., et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat. Rev. Gastroenterol. Hepatol. 9, 454-467 (2012).
37. Pauerstein, P. T., et al. Dissecting human gene functions regulating islet development with targeted gene transduction. Diabetes 64, 3037-3049 2015
38. Drost, J., et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43-47 (2015).
39. Kim, M. P., et al. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice. Nat. Protoc. 4, 1670-1680 (2009).
40. Pinto, M. P., Jacobsen, B. M., Horwitz, K. B. An immunohistochemical method to study breast cancer cell subpopulations and their growth regulation by hormones in three-dimensional cultures. Front. Endocrinol. 2, 15 (2011).
41. Dayem Ullah, A. Z., et al. The pancreatic expression database: recent extensions and updates. Nucleic Acids Res. 42, D944-D949 (2014).